Daniel Liebler

January 12, 2017

Team’s discovery offers new insight on lung cancer risk

Researchers in the Schools of Medicine and Engineering at Vanderbilt University have discovered a proteomic “signature” from the airways of heavy smokers that could lead to better risk assessment and perhaps new ways to stop lung cancer before it starts.

By Bill Snyder
November 12, 2015

Ayers Institute spurred key cancer research gains

In 2005, Tennessee philanthropists Jim and Janet Ayers gave $10 million to help Vanderbilt University scientists find early markers for colorectal cancer that could improve diagnosis and potentially save lives.

By Bill Snyder
February 19, 2015

Study sheds light on a ‘guardian’ protein of brain function

Mitochondria not only are the cell’s main power producers, they are also the chief cooks and bottle washers.

By Bill Snyder
September 4, 2014

VU study creates new road map for cellular activity

Human cells are constructed in large part from proteins whose activity can be altered by the incorporation of oxygen in what are known as redox modifications.

By VUMC News and Communications
July 24, 2014

Colon cancer’s protein signatures identified

A Vanderbilt University-led research team has identified protein “signatures” of genetic mutations that drive colorectal cancer, the nation’s second leading cause of cancer deaths after lung cancer.

By Bill Snyder
August 15, 2013

American Chemical Society honors VUMC’s Liebler

Daniel Liebler, Ph.D., Ingram Professor of Cancer Research, professor of Biochemistry, and director of the Ayers Institute for Precancer Detection and Diagnosis, has been selected as one of 96 fellows of the American Chemical Society (ACS), the world’s largest scientific society.

By Nancy Humphrey
December 20, 2012

Cancer markers from archived tissue

Archived tissue samples are yielding new disease biomarkers.
By VUMC News and Communications